Patient and family fact sheet. Myasthenia gravis: maximizing function.
Kernich
Catherine A
CA
Department of Neurology, University Hospitals Medical Group, Cleveland, Ohio, USA.
D017028:Caregivers / Q000193:education; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D018908:Muscle Weakness / Q000276:immunology* / Q000503:physiopathology*; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D009469:Neuromuscular Junction / Q000276:immunology* / Q000503:physiopathology*; D010956:Plasmapheresis / Q000379:methods / Q000592:standards; D040242:Risk Reduction Behavior; D013934:Thymectomy / Q000592:standards
D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents